Stock listing

Anatara Lifesciences Ltd

Selected listing: ANR · ASX · AUD · AU

Anatara Lifesciences Ltd (ASX:ANR), Health Technology. Latest release Sep 15, 2026: Anatara receives $318,402 in R&D Tax Incentive for FY26.

ANR:ASXAUDAUUpdated October 2, 2026
Anatara Lifesciences Ltd logo
Ticker
ASX:ANR
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
ASX
Currency
AUD

About Anatara Lifesciences Ltd

Anatara Lifesciences Ltd (Ticker: ANR) is a public company based in Australia, focusing on developing innovative solutions for health and wellness. Anatara aims to address significant health challenges through its research and development efforts.

Latest news from Anatara Lifesciences Ltd

Anatara receives $318,402 in R&D Tax Incentive for FY26

September 14, 2026

Appendix 4E & Financial Report 30 June 2026

August 18, 2026

Appendix 4D & Half Year Report 31 December 2025

February 25, 2026

Company Update

February 18, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 29, 2026

All Anatara Lifesciences Ltd news →

Research Anatara Lifesciences Ltd

Anatara Lifesciences Ltd company profile

View the public company page for Anatara Lifesciences Ltd on 6ix.

Anatara Lifesciences Ltd news

Read company news and market updates connected to Anatara Lifesciences Ltd.

Anatara Lifesciences Ltd investor events

Find investor webinars, events, and replay context for Anatara Lifesciences Ltd.